Dihydroartemisinin-sodium taurocholate-PLGA nanoparticles: a novel therapeutic approach against cystic echinococcosis
IntroductionDihydroartemisinin (DHA) demonstrates potent anti-echinococcal activity. However, its clinical application is constrained by non-specific biodistribution and low bioavailability. To overcome these limitations and enhance hepatic targeting, the DHA was encapsulated in poly (lactic-co-glyc...
Saved in:
| Main Authors: | Aierpati Moheteer, Jiang Zhu, Dongming Pang, Xue Rao, Nijiati Aini, Kalibixiati Aimulajiang, Zhenping Zhang, Saifuding Abula, Adelijiang Wusiman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1600525/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dihydroartemisinin enhances remyelination by switching microglia to the reparative phenotype
by: Li Liu, et al.
Published: (2025-08-01) -
Single-atom nanozyme-mediated dihydroartemisinin delivery for self-enhanced chemodynamic therapy and ferroptosis
by: Yuanlong Zhang, et al.
Published: (2025-10-01) -
Analytical validation of a LC-MS/MS based in vitro diagnostic kit for the quantification of L-tyrosine and taurocholic acid for liver fibrosis diagnosis
by: Guoxiang Xie, et al.
Published: (2025-04-01) -
Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
by: Jing-Jing Liu, et al.
Published: (2019-12-01) -
Dihydroartemisinin Alleviates the Symptoms of a Mouse Model of Systemic Lupus Erythematosus Through Regulating Splenic T/B-Cell Heterogeneity
by: Haihong Qin, et al.
Published: (2025-07-01)